Physician profile
David S Yorio
NPI 1487759171
$1,341.12
in general payments reported to CMS, 2019-2025
33 companies · $32.13 in 2025
The $32.13 reported for 2025 was less than what a typical Adolescent Medicine (Family Medicine) provider received nationally (typical 2025 total: $135).
See the full distribution for Adolescent Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $113 · 2020: $108 · 2021: $168 · 2022: $144 · 2023: $312 · 2024: $464 · 2025: $32.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $808.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $808.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $139.50 | 2023-2025 | Breztri, Farxiga |
| Abbvie INC. | $137.26 | 2022-2024 | Vraylar, Ubrelvy |
| Astellas Pharma US INC | $112.65 | 2019 | |
| Indivior INC. | $73.20 | 2020-2024 | Sublocade |
| Pfizer INC. | $62.98 | 2021-2025 | |
| Axsome Therapeutics, INC. | $57.70 | 2023-2024 | Auvelity, Sunosi |
| Antares Pharma, INC. | $55.98 | 2021-2022 | |
| Genentech USA, INC. | $52.75 | 2020-2022 | |
| Glaxosmithkline, LLC. | $44.91 | 2021-2024 | Trelegy Ellipta |
| Kowa Pharmaceuticals America, INC. | $43.46 | 2022 | |
| Medtronic, INC. | $41.68 | 2023 | Minimed 780g, Minimed 770g |
| Amarin Pharma, INC. | $36.92 | 2020-2021 | |
| Abbott Laboratories | $35.24 | 2022-2024 | Freestyle Libre 3 |
| Vivus LLC | $34.91 | 2020-2021 | |
| Phathom Pharmaceuticals, INC. | $32.72 | 2024 | Voquezna |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $29.11 | 2023 | Repatha, Otezla |
| Biodelivery Sciences International, INC. | $28.13 | 2020-2021 | |
| Exact Sciences Corporation | $27.98 | 2024 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $27.90 | 2024 | Xifaxan |
| Almatica Pharma LLC | $27.12 | 2023 | Loreev Xr, Gralise |
| Paratek Pharmaceuticals, INC. | $26.15 | 2024 | Nuzyra |
| Janssen Pharmaceuticals, INC | $24.72 | 2021 | |
| Angiodynamics, INC. | $24.20 | 2023 | Auryon Laser System 100-120 Vac |
| Inspire Medical Systems, INC. | $23.41 | 2024 | Inspire |
| Virtus Pharmaceuticals LLC | $19.33 | 2021 | |
| Advanced Oxygen Therapy INC. | $16.95 | 2023 | Topical Oxygen Chamber For Extremities |
| Lilly USA, LLC | $16.67 | 2023 | Jardiance |
| Otsuka America Pharmaceutical, INC. | $16.46 | 2024 | Rexulti |
| Regeneron Healthcare Solutions, INC. | $16.08 | 2023 | Dupixent |
| Braeburn INC. | $15.21 | 2024 | Brixadi |
| Phadia US INC. | $13.90 | 2024 | Immunocap |
| Mylan Specialty L.P. | $13.08 | 2021 | |
| Dermira, INC. | $12.86 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Yorio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.